171 related articles for article (PubMed ID: 527341)
41. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
[TBL] [Abstract][Full Text] [Related]
42. [Copper in the menstrual and physiological cycle cervical mucus of copper IUD users (author's transl)].
Ros A; Bouche M; Adami L; Mancaniello L
Contracept Fertil Sex (Paris); 1980 Jan; 8(1):11-6. PubMed ID: 12336140
[TBL] [Abstract][Full Text] [Related]
43. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
Sheppard BL; Bonnar J
Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
[TBL] [Abstract][Full Text] [Related]
44. Corpus luteum function in lactating women using the Progestasert system.
Abdalla MI; Ibrahim II; Osman MI; Badraoui MH; Askalani H
Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864
[TBL] [Abstract][Full Text] [Related]
45. Wider opportunities for IUD insertion.
Cole LP; Potts DM
IPPF Med Bull; 1983 Feb; 17(1):2-3. PubMed ID: 12264751
[TBL] [Abstract][Full Text] [Related]
46. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
Fylling P; Fagerhol M
Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
[TBL] [Abstract][Full Text] [Related]
47. [Use of the bio-active intrauterine devices TCu 200 and IPCS 52 during the post-partum period].
Lavin P; Bravo C; Waskaz C; Andrade MI; Bravo M; Caceres R; Castro J; Miranda L; Namur L; Olmos G
Contracept Fertil Sex (Paris); 1984 Mar; 12(3):483-8. PubMed ID: 12265945
[TBL] [Abstract][Full Text] [Related]
48. Thyroid function in lactating women using the Progestasert system.
Ibrahim II; Abdalla MI; Badraoui MH; Abdelaal AE
Contracept Deliv Syst; 1981 Apr; 2(1):139-44. PubMed ID: 12336866
[TBL] [Abstract][Full Text] [Related]
49. Endometrial cytology and leukocyte concentration in women bearing IUDs.
Ros A
Contracept Deliv Syst; 1980 Apr; 1(2):119-22. PubMed ID: 12336237
[TBL] [Abstract][Full Text] [Related]
50. [Comparative study on the clinical effects and endometrial findings of IUD].
Chao CK
Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
[TBL] [Abstract][Full Text] [Related]
51. Quantitative menstrual and intermenstrual blood loss in women using Lippes Loop and Copper T intrauterine devices.
Shaw ST; Andrade AT; Paixão de Souza J; Macaulay LK; Rowe PJ
Contraception; 1980 Apr; 21(4):343-52. PubMed ID: 7389355
[TBL] [Abstract][Full Text] [Related]
52. [Suspension of IUD sales in the United States: what are the international implications?].
Ramirez FJ; Starrs AM
Perspect Int Planif Fam; 1987; (Spec No):28-34. PubMed ID: 12269049
[TBL] [Abstract][Full Text] [Related]
53. Acceptability of IUDs is increasing.
Finger WR; Barr D
Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
[TBL] [Abstract][Full Text] [Related]
54. Serum-prolactin levels in lactating women using the Progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Contracept Deliv Syst; 1981 Apr; 2(1):121-6. PubMed ID: 12336863
[TBL] [Abstract][Full Text] [Related]
55. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1980 Feb; 87(2):155-62. PubMed ID: 7362803
[TBL] [Abstract][Full Text] [Related]
56. Intrauterine steroid contraceptives.
Scholten PC; Christaens GC; Haspels AA
Wien Med Wochenschr; 1987 Nov; 137(20-21):479-83. PubMed ID: 3131966
[TBL] [Abstract][Full Text] [Related]
57. [Use of Progestasert in the treatment of function dysmenorrhea].
Casella S
Minerva Ginecol; 1977; 29(7-8):607-10. PubMed ID: 927738
[TBL] [Abstract][Full Text] [Related]
58. Immediate post-termination insertion of Copper 7 and Dalkon Shield intrauterine contraceptive devices.
Newton J; Elias J; Johnson A
J Obstet Gynaecol Br Commonw; 1974 May; 81(5):389-92. PubMed ID: 4832320
[TBL] [Abstract][Full Text] [Related]
59. Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium.
Wan LS; Hsu YC; Ganguly M; Bigelow B
Contraception; 1977 Oct; 16(4):417-34. PubMed ID: 923252
[TBL] [Abstract][Full Text] [Related]
60. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
